Upgrade to SI Premium - Free Trial

Capricor Therapeutics (CAPR)

26.05 -0.67 (2.51%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/12/26)

Latest Headlines

Form 8-K CAPRICOR THERAPEUTICS, For: Jun 04 June 8, 2026 4:05 PM - SEC Filing Capricor Therapeutics to Present at Upcoming Investor Conferences June 8, 2026 9:25 AM - Globe NewsWire Form 4 CAPRICOR THERAPEUTICS, For: May 26 Filed by: Maurer Michael T May 28, 2026 9:55 PM - SEC Filing Form 3 CAPRICOR THERAPEUTICS, For: May 25 Filed by: Maurer Michael T May 28, 2026 9:52 PM - SEC Filing Form 4 CAPRICOR THERAPEUTICS, For: May 18 Filed by: Bergmann Anthony May 19, 2026 4:15 PM - SEC Filing Form 144/A CAPRICOR THERAPEUTICS, Filed by: Musket David B May 19, 2026 2:41 PM - SEC Filing Form 144 CAPRICOR THERAPEUTICS, Filed by: Musket David B May 19, 2026 11:40 AM - SEC Filing Form 4 CAPRICOR THERAPEUTICS, For: May 13 Filed by: Litvack Frank May 14, 2026 5:00 PM - SEC Filing Form 10-Q CAPRICOR THERAPEUTICS, For: Mar 31 May 13, 2026 5:21 PM - SEC Filing B.Riley Reiterates Buy Rating on Capricor Therapeutics (CAPR) May 13, 2026 4:15 AM - StreetInsider Capricor Therapeutics (CAPR) Misses Q1 EPS by 7c May 12, 2026 4:13 PM - StreetInsider Form 8-K CAPRICOR THERAPEUTICS, For: May 12 May 12, 2026 4:07 PM - SEC Filing Capricor Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update May 12, 2026 4:05 PM - Globe NewsWire Capricor sues NS Pharma over Duchenne therapy distribution deal May 8, 2026 7:15 AM - StreetInsider Form 8-K CAPRICOR THERAPEUTICS, For: May 07 May 7, 2026 4:41 PM - SEC Filing Form 4 CAPRICOR THERAPEUTICS, For: May 01 Filed by: Bergmann Anthony May 4, 2026 4:30 PM - SEC Filing Form 4 CAPRICOR THERAPEUTICS, For: May 01 Filed by: Krasney Karen May 4, 2026 4:30 PM - SEC Filing Capricor Therapeutics to Report First Quarter 2026 Financial Results and Provide Recent Corporate Update on May 12 May 4, 2026 4:05 PM - Globe NewsWire Capricor presents HOPE-3 trial data at neurology meeting April 22, 2026 9:02 AM - StreetInsider Capricor Therapeutics Announces Late-Breaking Presentation of HOPE-3 Phase 3 Results at the American Academy of Neurology 2026 Annual Meeting April 22, 2026 9:02 AM - Globe NewsWire Form ARS CAPRICOR THERAPEUTICS, For: Dec 31 April 10, 2026 5:18 PM - SEC Filing Form DEF 14A CAPRICOR THERAPEUTICS, For: Jun 04 April 10, 2026 4:31 PM - SEC Filing Form 4 CAPRICOR THERAPEUTICS, For: Apr 02 Filed by: Sabar Karimah Es April 3, 2026 5:00 PM - SEC Filing Form 144 CAPRICOR THERAPEUTICS, Filed by: Sabar Karimah Es April 2, 2026 4:24 PM - SEC Filing Form 4 CAPRICOR THERAPEUTICS, For: Mar 31 Filed by: Krasney Karen April 1, 2026 8:00 PM - SEC Filing Form 4 CAPRICOR THERAPEUTICS, For: Mar 31 Filed by: Sabar Karimah Es April 1, 2026 8:00 PM - SEC Filing Form 4 CAPRICOR THERAPEUTICS, For: Mar 31 Filed by: Bergmann Anthony April 1, 2026 8:00 PM - SEC Filing Form PRE 14A CAPRICOR THERAPEUTICS, For: May 22 March 31, 2026 5:24 PM - SEC Filing Form 144 CAPRICOR THERAPEUTICS, Filed by: Krasney Karen March 31, 2026 4:24 PM - SEC Filing Form 144 CAPRICOR THERAPEUTICS, Filed by: Bergmann Anthony March 31, 2026 4:23 PM - SEC Filing Form 144 CAPRICOR THERAPEUTICS, Filed by: Sabar Karimah Es March 31, 2026 4:23 PM - SEC Filing Form 4 CAPRICOR THERAPEUTICS, For: Dec 30 Filed by: Krasney Karen March 27, 2026 7:15 PM - SEC Filing Full Article List